Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism

S Berger1, M Bleich, W Schmid

  • 1Division Molecular Biology of the Cell I, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

Insights

Mineralocorticoid receptor (MR)-deficient mice exhibit pseudohypoaldosteronism and die from dehydration due to renal sodium loss. This highlights MR

Area of Science:

  • Physiology
  • Genetics
  • Molecular Biology

Background:

  • The mineralocorticoid receptor (MR) plays a crucial role in regulating sodium and potassium balance.
  • Understanding MR's function is vital for treating conditions like pseudohypoaldosteronism.

Purpose of the Study:

  • To investigate the physiological consequences of MR deficiency in mice.
  • To elucidate the role of MR in renal and colonic sodium reabsorption.

Main Methods:

  • Generation of MR-deficient mice using gene targeting.
  • In vivo measurement of renal clearance and colonic sodium reabsorption.
  • Analysis of epithelial sodium channels (ENaC) and Na+/K+-ATPase expression.

Main Results:

  • MR-deficient mice displayed symptoms of pseudohypoaldosteronism, including dehydration, hyperkalemia, and hyponatremia.
  • Elevated renal sodium excretion and reduced amiloride-sensitive sodium reabsorption in kidney and colon were observed.
  • No significant changes in ENaC or Na+/K+-ATPase RNA levels were detected.

Conclusions:

  • MR deficiency leads to lethal renal sodium and water loss in neonates.
  • MR regulates sodium reabsorption through transcriptional control of unidentified genes, not directly ENaC or Na+/K+-ATPase.
  • MR knockout mice are a valuable model for identifying novel MR-regulated genes.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...